Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO
Takashi Unoki(Saiseikai Kumamoto Hospital), Junjiroh Koyama(Saiseikai Kumamoto Hospital), Yoshinori Tsurusaki(Yokohama City University), Yutaka Konami(Saiseikai Kumamoto Hospital), Tomoko Nakayama(Saiseikai Kumamoto Hospital), T Toyofuku(Saiseikai Kumamoto Hospital), Tomohiro Sakamoto(Saiseikai Kumamoto Hospital), Koichi Kodama(Saiseikai Kumamoto Hospital), Hiroto Suzuyama(Saiseikai Kumamoto Hospital), Eiji Taguchi(Saiseikai Kumamoto Hospital), Eiji Horio(Kumamoto University), Kōichi Nakao(Kanazawa Seiryo University), Toru Inamori(Saiseikai Kumamoto Hospital), Masaaki Inoue(Saiseikai Kumamoto Hospital), Tadashi Sawamura(Saiseikai Kumamoto Hospital)
Cited by 6
Related Papers
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|453
Myosin heavy chain gene expression in human heart failure.
|Journal of Clinical Investigation|1997|422